Medicare Enrolled
Dr. Hans Kim, M.D.
Ophthalmology · Los Angeles, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kim from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kim?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kim
Dr. Hans Kim is an ophthalmology specialist in Los Angeles, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Kim performed 8,406 Medicare services across 4,198 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kim received a total of $10,251 from 35 pharmaceutical and/or device companies across 388 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kim is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 11% volume in CA
$10,251 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,406
Medicare services
Top 11% in CA for ophthalmology
4,198
Unique beneficiaries
$144
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~442 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Eye exam, established patient, focused A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom. |
1,885 | $76 | $120 |
| Aflibercept eye injection (Eylea) | 874 | $693 | $1,850 |
| Retinal photography (fundus photo) This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures. |
603 | $28 | $120 |
| Removal of eye fluid | 529 | $102 | $300 |
| Eye injection for retinal disease A procedure involving the administration of medication directly into the eye. |
528 | $50 | $500 |
| Ultrasound of eye tissue and structures A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures. |
488 | $41 | $200 |
| Retinal and optic nerve function test A diagnostic test that measures how well the retina and optic nerve are functioning. |
481 | $111 | $250 |
| Retinal imaging (OCT scan) This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye. |
446 | $35 | $100 |
| Comprehensive eye exam, established patient A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider. |
431 | $101 | $160 |
| Tear duct plug insertion A procedure to insert a small plug into the tear duct opening to help retain tears on the eye surface. |
369 | $193 | $335 |
| Retinal angiography with dye injection This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body. |
309 | $122 | $200 |
| Visual field test, extended A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam. |
294 | $54 | $120 |
| Extended eye exam with retinal drawing A detailed examination of the back of the eye that includes creating a drawing of the retina. |
236 | $21 | $75 |
| Laser repair to improve eye fluid flow A laser procedure used to enhance the drainage of fluid within the eye. |
126 | $212 | $600 |
| Removal of foreign body from external eye This procedure involves the removal of a foreign object from the surface of the eye, specifically from the conjunctiva or sclera. |
104 | $38 | $237 |
| Ultrasound of eye using water bath method An ultrasound imaging test of the eye that uses a water bath technique to visualize internal eye structures. |
91 | $63 | $200 |
| Compounded drug, not otherwise classified A medication prepared specifically for an individual patient by a pharmacist or physician, tailored to meet unique needs that cannot be fulfilled by commercially available products. |
89 | $74 | $294 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
83 | $129 | $200 |
| Eyelash removal with forceps This procedure involves the manual removal of eyelashes using forceps. It is a mechanical extraction method performed on the eyelid area. |
59 | $13 | $160 |
| Optic nerve imaging (OCT scan) Imaging of the optic nerve. |
58 | $31 | $100 |
| Eye drainage system examination An examination of the internal drainage system of the eye to assess how fluid flows and drains from the eye. |
51 | $23 | $65 |
| Nasal tear duct probing A procedure to examine and clear the tear ducts in the nose. It helps restore normal drainage of tears from the eye. |
44 | $173 | $320 |
| Corneal topography and eye depth measurement This procedure measures the curvature and depth of the cornea, the clear front surface of the eye. |
38 | $42 | $250 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
37 | $78 | $160 |
| Ultrasound scan of cornea to determine thickness An ultrasound procedure used to measure the thickness of the cornea. |
33 | $9 | $80 |
| Laser removal of recurring cataract A laser procedure to remove a recurring cataract within the lens capsule. |
32 | $293 | $550 |
| Dilation of eye fluid drainage A procedure to widen the drainage pathways in the eye to help fluid flow out more easily. |
27 | $320 | $1,500 |
| Complex cataract removal with lens implant A surgical procedure to remove a cataract from the eye and insert an artificial lens to restore vision. |
25 | $642 | $2,000 |
| Removal of outer layer of cornea This procedure involves the removal of the outermost layer of the cornea, which is the clear front surface of the eye. |
12 | $92 | $233 |
| Medication injection into the eye A procedure involving the injection of medication directly into the eye. The specific type of medication or clinical purpose is not defined in the provided description. |
12 | $49 | $500 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
12 | $72 | $120 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$10,251
Total received (2018-2024)
Avg $1,464/year across 7 years
Top 14% in CA for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
35
Companies
388
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,251 (90.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,000 (9.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,756
2023
$890
2022
$1,211
2021
$1,302
2020
$840
2019
$1,669
2018
$2,583
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$1,040
Cardinal Health 110 LLC
$150
Amgen Inc.
$103
Bausch & Lomb Americas Inc.
$102
ABBVIE INC.
$82
Alcon Vision LLC
$63
Dompe US, Inc.
$52
SUN PHARMACEUTICAL INDUSTRIES INC.
$46
Oyster Point Pharma, Inc.
$30
Sight Sciences, Inc.
$24
Tarsus Pharmaceuticals, Inc.
$22
Genentech USA, Inc.
$21
Thea Pharma Inc.
$21
Top 3 companies account for 73.6% of 2024 payments
All-time payments by company (2018-2024) ›
Aerie Pharmaceuticals, Inc.
$1,073
Boston Scientific Corporation
$1,040
Bausch & Lomb, a division of Bausch Health US, LLC
$894
Dutch Ophthalmic Research Center (International) B.V.
$850
Novartis Pharmaceuticals Corporation
$688
Sun Pharmaceutical Industries Inc.
$648
Shire North American Group Inc
$591
Allergan, Inc.
$588
Sight Sciences, Inc.
$580
Allergan Inc.
$492
Bausch & Lomb Americas Inc.
$308
Alcon Vision LLC
$291
Regeneron Healthcare Solutions, Inc.
$277
Horizon Therapeutics plc
$197
Akorn, Inc.
$176
Akorn Operating Company LLC
$176
Oyster Point Pharma, Inc.
$172
ABBVIE INC.
$155
Cardinal Health 110 LLC
$150
GENZYME CORPORATION
$120
Amgen Inc.
$103
Thea Pharma Inc.
$97
Dompe US, Inc.
$73
Kala Pharmaceuticals, Inc.
$72
SUN PHARMACEUTICAL INDUSTRIES INC.
$69
Eyevance Pharmaceuticals LLC
$65
Genentech USA, Inc.
$50
Glaukos Corporation
$49
Alimera Sciences, Inc.
$46
EYEVANCE PHARMACEUTICALS LLC
$35
Alcon Laboratories Inc
$34
Optos, Inc.
$25
TOPCON HEALTHCARE SOLUTIONS, INC.
$25
Tarsus Pharmaceuticals, Inc.
$22
Carl Zeiss Meditec AG
$19
Top 3 companies account for 29.3% of all-time payments
Associated products mentioned in payments ›
ALPHAGAN P · ARGOS · AcrySof IQ PanOptix · AzaSite · BROMSITE · Betimol · CEQUA · Cequa · Cosopt · Cosopt PF · DUREZOL · DURYSTA · EVA Ophthalmic Surgical System · EYLEA · EYLEA HD · EYSUVIS · Flarex · HARMONY · ILEVRO · ILUVIEN · INVELTYS · IYUZEH · Iluvien · KEVZARA · LOTEMAX GEL · LOTEMAX SM · LUMIGAN · MIEBO · None Specified · OCT OPHTHALMOSCOPE · OMNI · OMNI SURGICAL SYSTEM · OMNI Surgical System · OMNI(R) SURGICAL SYSTEM (US) · OXERVATE · OZURDEX · PAZEO · PROLENSA · RESTASIS · RESTASIS MULTIDOSE · ReSTOR · Rhopressa · Rocklatan · Simbrinza · SpaceOAR System · TEPEZZA · TRAVATAN Z · TYRVAYA · Tobradex ST · VUITY · VYZULTA · Vabysmo · XDEMVY · XELPROS · XEN GLAUCOMA TREATMENT SYSTEM · XIIDRA · Zioptan · iStent inject W · rhopressa · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (90%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Ophthalmologists within 10 mi
768
Per 100K population
7.8
County median income
$87,760
Nearest hospital
DOCS SURGICAL HOSPITAL
2.3 mi
2.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kim is a mixed practice specialist, with above-average Medicare volume (top 11% in CA), with low-engagement industry engagement in the top 14% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kim experienced with eye exam, established patient, focused?
Based on Medicare claims data, Dr. Kim performed 1,885 eye exam, established patient, focused services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kim receive payments from pharmaceutical companies?
Yes. Dr. Kim received a total of $10,251 from 35 companies across 388 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kim's costs compare to other ophthalmologists in Los Angeles?
Dr. Kim's average Medicare payment per service is $144. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kim) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Ophthalmologists in Los Angeles
Browse ophthalmologists in Los Angeles ranked by procedure volume and transparency data.
Highest volume
Top Ophthalmologists in CA
Ophthalmologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Ophthalmologists in CA
Which CA ophthalmologists receive the most from drug and device companies.
By company
Aerie Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Aerie Pharmaceuticals, Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Bausch & Lomb, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Bausch & Lomb, a division of Bausch Health US, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology